| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2007-11-29 | 2007-09-30 | N-Q | Millennium Pharmaceuticals Inc | MLNM | US | Medical-Biomedical/Gene | 341,947 | Added More | 147,166 | 75.55 % | $5,105,269 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Millennium Pharmaceuticals Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Cephalon Inc | CEPH | US | Medical-Drugs | 43,982 | Added More | 12,332 | 38.96 % | $3,291,173 | $2,621,767 | $-669,406 | -20.33 % | $-187,693 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Cephalon Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 47,457 | Added More | 19,086 | 67.27 % | $3,618,122 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Genentech Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Invitrogen Corp | IVGN | US | Medical-Biomedical/Gene | 47,969 | Added More | 13,421 | 38.84 % | $4,609,821 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Invitrogen Corp |
| 2007-11-29 | 2007-09-30 | N-Q | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 82,703 | Added More | 26,191 | 46.34 % | $3,072,416 | $1,028,825 | $-2,043,591 | -66.51 % | $-647,180 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Millipore Corp | MIL | US | Medical-Biomedical/Gene | 45,983 | Added More | 14,562 | 46.34 % | $3,731,061 | $3,114,429 | $-616,632 | -16.52 % | $-195,276 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Millipore Corp |
| 2007-11-29 | 2007-09-30 | N-Q | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 61,591 | Added More | 24,305 | 65.18 % | $3,849,438 | $3,381,962 | $-467,476 | -12.14 % | $-184,475 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Celgene Corp |
| 2007-11-29 | 2007-09-30 | N-Q | Nektar Therapeutics | NKTR | US | Medical-Biomedical/Gene | 409,168 | Added More | 227,429 | 125.14 % | $2,675,959 | $3,535,212 | $859,253 | 32.11 % | $477,601 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Nektar Therapeutics |
| 2007-11-29 | 2007-09-30 | N-Q | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 59,215 | Added More | 22,303 | 60.42 % | $4,434,611 | $2,963,711 | $-1,470,901 | -33.16 % | $-554,007 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Genzyme Corp |
| 2007-11-29 | 2007-09-30 | N-Q | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 418,281 | Added More | 205,197 | 96.29 % | $4,375,219 | $11,452,534 | $7,077,315 | 161.75 % | $3,471,933 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Human Genome Sciences Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Gilead Sciences Inc | GILD | US | Therapeutics | 90,729 | Added More | 35,743 | 65.00 % | $4,151,759 | $4,208,918 | $57,159 | 1.37 % | $22,518 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Gilead Sciences Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 107,062 | Added More | 45,745 | 74.60 % | $4,874,533 | $3,510,563 | $-1,363,970 | -27.98 % | $-582,791 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Osi Pharmaceuticals Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 122,805 | Added More | 49,514 | 67.55 % | $3,082,406 | $4,732,905 | $1,650,499 | 53.54 % | $665,468 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 144,430 | Added More | 64,275 | 80.18 % | $2,374,429 | $1,558,400 | $-816,030 | -34.36 % | $-363,154 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Intermune Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 65,592 | Added More | 15,486 | 30.90 % | $4,773,130 | $3,042,157 | $-1,730,973 | -36.26 % | $-408,676 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Biogen Idec Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Pdl Biopharma Inc | PDLI | US | Medical-Biomedical/Gene | 138,931 | Added More | 42,151 | 43.55 % | $2,446,575 | $1,097,555 | $-1,349,020 | -55.13 % | $-409,286 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Pdl Biopharma Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Affymetrix Inc | AFFX | US | Medical-Biomedical/Gene | 142,184 | Added More | 68,054 | 91.80 % | $2,985,864 | $688,171 | $-2,297,693 | -76.95 % | $-1,099,753 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Affymetrix Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Imclone Systems Inc | IMCL | US | Therapeutics | 100,203 | Added More | 44,377 | 79.49 % | $4,409,934 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Imclone Systems Inc |
| 2007-11-29 | 2007-09-30 | N-Q | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 64,095 | Added More | 26,420 | 70.12 % | $3,554,709 | $3,549,581 | $-5,128 | -0.14 % | $-2,114 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Amgen Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 37,675 | Added More | 19,459 | 106.82 % | $1,917,658 | $2,086,442 | $168,784 | 8.80 % | $87,176 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Amgen Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Millennium Pharmaceuticals Inc | MLNM | US | Medical-Biomedical/Gene | 194,781 | Added More | 74,442 | 61.86 % | $1,938,071 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Millennium Pharmaceuticals Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Cephalon Inc | CEPH | US | Medical-Drugs | 31,650 | Added More | 14,028 | 79.60 % | $2,369,319 | $1,886,657 | $-482,663 | -20.37 % | $-213,927 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Cephalon Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 80,155 | Added More | 39,102 | 95.24 % | $1,595,886 | $864,872 | $-731,014 | -45.80 % | $-356,610 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Intermune Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Millipore Corp | MIL | US | Medical-Biomedical/Gene | 31,421 | Added More | 11,635 | 58.80 % | $2,251,000 | $2,128,144 | $-122,856 | -5.45 % | $-45,493 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Millipore Corp |
| 2007-09-07 | 2007-06-30 | N-CSRS | Medimmune Inc | MDU.BE | US | Medical-Biomedical/Gene | 0 | Sold All | -35,357 | -100 % | - | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Medimmune Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Imclone Systems Inc | IMCL | US | Therapeutics | 55,826 | Added More | 10,704 | 23.72 % | $2,051,047 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Imclone Systems Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Invitrogen Corp | IVGN | US | Medical-Biomedical/Gene | 34,548 | Added More | 11,803 | 51.89 % | $2,763,840 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Invitrogen Corp |
| 2007-09-07 | 2007-06-30 | N-CSRS | Nektar Therapeutics | NKTR | US | Medical-Biomedical/Gene | 181,739 | Added More | 89,370 | 96.75 % | $1,542,964 | $1,570,225 | $27,261 | 1.76 % | $13,406 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Nektar Therapeutics |
| 2007-09-07 | 2007-06-30 | N-CSRS | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 61,317 | New Holding | 61,317 | 100 % | $2,162,037 | $2,010,584 | $-151,453 | -7.00 % | $-151,453 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Osi Pharmaceuticals Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Pdl Biopharma Inc | PDLI | US | Medical-Biomedical/Gene | 96,780 | Added More | 39,478 | 68.89 % | $1,941,407 | $764,562 | $-1,176,845 | -60.61 % | $-480,052 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Pdl Biopharma Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 213,084 | Added More | 100,280 | 88.89 % | $1,956,111 | $5,834,240 | $3,878,129 | 198.25 % | $1,825,096 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Human Genome Sciences Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 28,371 | Added More | 13,207 | 87.09 % | $2,243,862 | - | - | - % | | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Genentech Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 56,512 | Added More | 22,562 | 66.45 % | $2,714,836 | $703,009 | $-2,011,827 | -74.10 % | $-803,207 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 37,286 | Added More | 13,321 | 55.58 % | $2,426,200 | $2,047,374 | $-378,826 | -15.61 % | $-135,341 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Celgene Corp |
| 2007-09-07 | 2007-06-30 | N-CSRS | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 36,912 | Added More | 16,987 | 85.25 % | $2,321,765 | $1,847,446 | $-474,319 | -20.42 % | $-218,283 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Genzyme Corp |
| 2007-09-07 | 2007-06-30 | N-CSRS | Gilead Sciences Inc | GILD | US | Therapeutics | 54,986 | Added More | 34,368 | 166.68 % | $2,070,773 | $2,550,801 | $480,028 | 23.18 % | $300,033 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Gilead Sciences Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 73,291 | Added More | 36,675 | 100.16 % | $2,913,317 | $2,824,635 | $-88,682 | -3.04 % | $-44,377 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 50,106 | Added More | 24,031 | 92.16 % | $3,295,973 | $2,323,916 | $-972,056 | -29.49 % | $-466,201 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Biogen Idec Inc |
| 2007-09-07 | 2007-06-30 | N-CSRS | Affymetrix Inc | AFFX | US | Medical-Biomedical/Gene | 74,130 | Added More | 19,624 | 36.00 % | $1,719,075 | $358,789 | $-1,360,286 | -79.12 % | $-360,100 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Amex Biotechnology Index Fund Ownership Of Affymetrix Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |